After the treatment of breast cancer mouse models with neoadjuvant chemotherapy drugs, macrophages expressed more YKL-39, which is a newly discovered chemokine promoting the recruitment and infiltration of monocytes from blood to tumor sites [71]. This evidence concerns the gene CHI3L2 and breast carcinoma.